Ionis Pharmaceuticals in (ions 1.75 06/15/28)

13F holders, Q2 2026 (June 30)
8holders −1
4new positions
4sold out
$1.75avg. 13F price*

At the end of Q2 2026, 8 institutions reported holding Ionis Pharmaceuticals in (ions 1.75 06/15/28) in their 13F filings, down 1 from Q1 2026. 4 opened new positions and 4 sold out. The largest holders were Focus Partners Wealth ($8.1M), Picton Mahoney Asset Management ($7.8M) and State of Wisconsin Investment Board ($6.2M).

Company
Ionis Pharmaceuticals in (ions 1.75 06/15/28)
CUSIP
462222AF7
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q2 2024: 4Q2 2024Q3 2024: 3Q3 2024Q4 2024: 6Q4 2024Q1 2025: 5Q1 2025Q2 2025: 6Q2 2025Q3 2025: 6Q3 2025Q4 2025: 8Q4 2025Q1 2026: 9Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions4$7.9M
Exits4$10.6M

All 13F filers, Q1 2026 → Q2 2026: 6,107,000 shares bought and 5,760,805 shares sold, net +346,195 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 8 holders

Focus Partners Wealth 0.01% Reduce -1.9% 5,176,000 $8.1M
Picton Mahoney Asset Management 0.07% New 5,000,000 $7.8M
State of Wisconsin Investment Board 0.01% Add +33.3% 4,000,000 $6.2M
Nomura Holdings Inc. 0.01% Reduce -57.7% 35,977 $2.9M
Oppenheimer Asset Management Inc. 0.00% New 72,000 $112K
Stephens Inc. 0.00% New 24,000 $37K
Commonwealth Equity Services, LLC 0.00% New 11,000 $17K
Oddo BHF Asset Management Sas 0.00% Reduce -26.7% 274 $427

"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 1.75 06/15/28)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 1.75 06/15/28) the manager owns.